Literature DB >> 22318545

Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Gurusamy Umamaheswaran1, Dhakchinamoorthi Krishna Kumar, Dhandapani Kayathiri, Subramanian Rajan, Deepak Gopal Shewade, Steven Aibor Dkhar, Sajjanavar Manjunath, Prayaga Ushakiran, Gangadharan Reneega, Kukreti Ritushree, Chandrasekaran Adithan.   

Abstract

Molecular variants of polymorphic drug metabolizing enzymes and drug transporters are attributed to differences in individual's therapeutic response and drug toxicity in different populations. We sought to determine the genotype and allele frequencies of polymorphisms for major phase II drug-metabolizing enzymes (TPMT, UGT1A1) and drug transporter (MDR1) in South Indians. Allelic variants of TPMT (*2,*3A,*3B,*3C & *8), UGT1A1 (TA)6>7 and MDR1 (2677G>T/A & 3435C>T) were evaluated in 450-608 healthy South Indian subjects. Genomic DNA was extracted by phenol-chloroform method and genotype was determined by PCR-RFLP, qRT-PCR, allele specific PCR, direct sequencing and SNaPshot techniques. The frequency distributions of TPMT, UGT1A1 and MDR1 gene polymorphisms were compared between the individual 4 South Indian populations viz., Tamilian, Kannadiga, Andhrite and Keralite. The combined frequency distribution of the South Indian populations together, was also compared with that of other major populations. The allele frequencies of TPMT*3C, UGT1A1 (TA)7, MDR1 2677T, 2677A and 3435T were 1.2, 39.8, 60.3, 3.7, and 61.6% respectively. The other variant alleles such as TPMT*2, *3A, *3B and *8 were not identified in the South Indian population. Sub-population analysis showed that the distribution of UGT1A1 (TA)6>7 and MDR1 allelic variants differed between the four ethnic groups. However, the frequencies of TPMT*3C allele were similar in the four South Indian populations. The distribution of TPMT, UGT1A1 and MDR1 gene polymorphisms of the South Indian population was significantly different from other populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318545     DOI: 10.1007/s11033-012-1456-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  73 in total

1.  Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study.

Authors:  Clive M Onnie; Sheila A Fisher; Reenal Pattni; Jeremy Sanderson; Alastair Forbes; Cathryn M Lewis; Christopher G Mathew
Journal:  Inflamm Bowel Dis       Date:  2006-04       Impact factor: 5.325

2.  Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.

Authors:  Chava Kimchi-Sarfaty; Andrew H Marple; Shiri Shinar; Avraham M Kimchi; David Scavo; M Isabella Roma; In-Wha Kim; Adam Jones; Mili Arora; John Gribar; David Gurwitz; Michael M Gottesman
Journal:  Pharmacogenomics       Date:  2007-01       Impact factor: 2.533

3.  Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease.

Authors:  S Ardizzone; G Maconi; V Bianchi; A Russo; E Colombo; A Cassinotti; C Penati; M L Tenchini; G Bianchi Porro
Journal:  Inflamm Bowel Dis       Date:  2007-05       Impact factor: 5.325

4.  Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers.

Authors:  Ping Xu; Zhi-Ping Jiang; Bi-Kui Zhang; Ji-Ying Tu; Huan-De Li
Journal:  Pharmacology       Date:  2008-09-23       Impact factor: 2.547

5.  Genotype frequencies of UDP-glucuronosyltransferase 1A1 promoter gene polymorphism in the population of healthy Croatian pre-scholars.

Authors:  Natalija Marinković; Daria Pasalić; Branka Grsković; Goran Ferencak; Lorena Honović; Ana Stavljenić Rukavina
Journal:  Coll Antropol       Date:  2008-09

Review 6.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

7.  MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese.

Authors:  Tatsuya Osuga; Toshiyuki Sakaeda; Tsutomu Nakamura; Toshio Yamada; Tatsuya Koyama; Takao Tamura; Nobuo Aoyama; Noboru Okamura; Masato Kasuga; Katsuhiko Okumura
Journal:  Biol Pharm Bull       Date:  2006-02       Impact factor: 2.233

8.  Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans.

Authors:  Dezheng Huo; Hee-Jin Kim; Clement A Adebamowo; Temidayo O Ogundiran; Effiong E Akang; Oladapo Campbell; Adeniyi Adenipekun; Qun Niu; Lise Sveen; James D Fackenthal; Donna Lee Fackenthal; Soma Das; Nancy Cox; Anna Di Rienzo; Olufunmilayo I Olopade
Journal:  Breast Cancer Res Treat       Date:  2007-10-02       Impact factor: 4.872

9.  Gilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult population.

Authors:  Aspasia Tsezou; Maria Tzetis; Eirini Giannatou; Ierotheos Spanos; Eleutheria Roma; Alexandros Fretzayas; Emmanuel Kanavakis; Sofia Kitsiou-Tzeli
Journal:  Genet Test Mol Biomarkers       Date:  2009-02

Review 10.  Clinical pharmacology and pharmacogenetics of thiopurines.

Authors:  Srikumar Sahasranaman; Danny Howard; Sandip Roy
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 3.064

View more
  8 in total

1.  Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance.

Authors:  Sandeep Kirit Davavala; Devendra C Desai; Philip Abraham; Tester Ashavaid; Anand Joshi; Tarun Gupta
Journal:  Indian J Gastroenterol       Date:  2013-08-31

2.  Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian population.

Authors:  Gurusamy Umamaheswaran; Steven Aibor Dkhar; Sekar Kalaivani; Raj Anjana; Mohan Revathy; Mohammad Jaharamma; Kulumani Mahadevan Lakshmi Shree; Dharanipragada Kadambari; Chandrasekaran Adithan
Journal:  Med Oncol       Date:  2013-07-28       Impact factor: 3.064

Review 3.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

4.  Inter and intra ethnic variation of vitamin K epoxide reductase complex and cytochrome P450 4F2 genetic polymorphisms and their prevalence in South Indian population.

Authors:  Dhakchinamoorthi Krishna Kumar; Deepak Gopal Shewade; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Chandrasekaran Adithan
Journal:  Indian J Hum Genet       Date:  2013-07

5.  Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia.

Authors:  Vijay Gandhi Linga; Dorra Babu Patchva; Krishna Mohan Mallavarapu; Venkata Tulasi; Krishnamani Iyer Kalpathi; Ashok Pillai; Sadashivudu Gundeti; Senthil J Rajappa; Raghunadharao Digumarti
Journal:  Indian J Med Paediatr Oncol       Date:  2014-10

6.  Genetic variation and haplotype structure of the gene Vitamin K epoxide reductase complex, subunit 1 in the Tamilian population.

Authors:  Dhakchinamoorthi Krishna Kumar; Deepak Gopal Shewade; Adithan Surendiran; Chandrasekaran Adithan
Journal:  J Pharmacol Pharmacother       Date:  2013-01

7.  Genotype, allele and haplotype frequencies of four TCL1A gene polymorphisms associated with musculoskeletal toxicity in the South Indian descent.

Authors:  Gurusamy Umamaheswaran; Steven Aibor Dkhar; Annan Sudarsan Arun Kumar; Rao Katiboina Srinivasa; Dharanipragada Kadambari; Chandrasekaran Adithan
Journal:  Bioimpacts       Date:  2014-06-19

8.  Relationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disorders.

Authors:  Xindi Li; Shenghui Mei; Xiaoqing Gong; Heng Zhou; Li Yang; Anna Zhou; Yonghong Liu; Xingang Li; Zhigang Zhao; Xinghu Zhang
Journal:  BMC Neurol       Date:  2017-07-05       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.